Lixte Biotechnology Holdings, Inc.

LIXTNASDAQHealthcare● Active

$6.65

$-0.35(-5.00%)

Market Cap$82346285

P/E Ratio—

52W High$7.5

52W Low$0.64

Avg Volume80K

Open$7.24

Beta1.05

Overview

Lixte Biotechnology Holdings, Inc. (LIXT) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

LIXT · earnings · updated Jun 9, 2026

Latest Earnings

Q2 FY2026Report Date: May 14, 2026

EPS Actual

-$0.18

Revenue

—

Fiscal Period

Q2 FY2026

FY ends December

Report Date

May 14, 2026

After Market Close

LIXT reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q2 FY2026	May 14, 2026	—	-$0.18	—	—	—	—
— Q1 FY2026	Mar 31, 2026	—	-$0.33	—	—	—	—
— Q4 FY2025	Nov 12, 2025	—	-$0.33	—	—	—	—
— Q3 FY2025	Aug 7, 2025	—	-$0.29	—	—	—	—
— Q2 FY2025	May 12, 2025	—	-$0.29	—	—	—	—
— Q1 FY2025	Mar 24, 2025	—	-$0.27	—	—	—	—
— Q4 FY2024	Nov 12, 2024	—	-$0.44	—	—	—	—
— Q3 FY2024	Aug 8, 2024	—	-$0.45	—	—	—	—

Q2 FY2026

May 14, 2026

EPS Actual

-$0.18

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2026

Mar 31, 2026

EPS Actual

-$0.33

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2025

Nov 12, 2025

EPS Actual

-$0.33

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2025

Aug 7, 2025

EPS Actual

-$0.29

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2025

May 12, 2025

EPS Actual

-$0.29

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2025

Mar 24, 2025

EPS Actual

-$0.27

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2024

Nov 12, 2024

EPS Actual

-$0.44

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Aug 8, 2024

EPS Actual

-$0.45

EPS Est.

—

EPS Surpr.

—

Revenue

—

No analyst estimates available for LIXT.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q2 FY2026	May 14, 2026	—	$5.00	$5.04	+0.80%
— Q1 FY2026	Mar 31, 2026	—	$3.13	$3.07	-1.92%
— Q4 FY2025	Nov 12, 2025	—	$4.41	$4.75	+7.71%
— Q3 FY2025	Aug 7, 2025	—	$4.48	$4.88	+8.93%
— Q2 FY2025	May 12, 2025	—	$1.22	$1.28	+4.92%
— Q1 FY2025	Mar 24, 2025	—	$1.30	$1.34	+3.08%
— Q4 FY2024	Nov 12, 2024	—	$1.65	$1.68	+1.82%
— Q3 FY2024	Aug 8, 2024	—	$2.06	$2.16	+4.85%

Q2 FY2026+0.80%

Report Date

May 14, 2026

EPS Beat/Miss

—

Price Before

$5.00

Price After

$5.04

Q1 FY2026-1.92%

Report Date

Mar 31, 2026

EPS Beat/Miss

—

Price Before

$3.13

Price After

$3.07

Q4 FY2025+7.71%

Report Date

Nov 12, 2025

EPS Beat/Miss

—

Price Before

$4.41

Price After

$4.75

Q3 FY2025+8.93%

Report Date

Aug 7, 2025

EPS Beat/Miss

—

Price Before

$4.48

Price After

$4.88

Q2 FY2025+4.92%

Report Date

May 12, 2025

EPS Beat/Miss

—

Price Before

$1.22

Price After

$1.28

Q1 FY2025+3.08%

Report Date

Mar 24, 2025

EPS Beat/Miss

—

Price Before

$1.30

Price After

$1.34

Q4 FY2024+1.82%

Report Date

Nov 12, 2024

EPS Beat/Miss

—

Price Before

$1.65

Price After

$1.68

Q3 FY2024+4.85%

Report Date

Aug 8, 2024

EPS Beat/Miss

—

Price Before

$2.06

Price After

$2.16

Beat Rate0 / 8 quarters

Largest Move+8.93% (Q3 FY2025)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Lixte Biotechnology Holdings, Inc. (LIXT) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-0.18 (in line with the analyst consensus of —). The next LIXT earnings date is expected around September 1, 2026.

Each quarter, investors track LIXT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. LIXT revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

LIXT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

LIXT earnings · 4 questions

Lixte Biotechnology Holdings, Inc.'s next earnings report is expected around September 1, 2026. LIXT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; LIXT historically reports after market close (AMC).

LIXT earnings datewhen is LIXT earningsLIXT next earnings datewhen does LIXT report earningsLIXT earnings calendar

▸ Source: FMP · Lixte Biotechnology Holdings, Inc. SEC filings · US GAAP · Lixte Biotechnology Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026